Looking for our Business Solutions? Click here:CloudQuote APIsContact Us

Articles from Epineuron Technologies Inc.

Epineuron Receives FDA 510(k) Clearance for Evala® Nerve Stimulator
Epineuron, a medical device company pioneering bioelectronic medicine, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Evala® Nerve Stimulator. This handheld, intraoperative electrical stimulation device is engineered to provide surgeons with a rapid and accurate solution for nerve identification and functional evaluation of different nerve sizes, large and small. This milestone marks a significant expansion of the company’s portfolio and commercial footprint of its proprietary bioelectronic platform for peripheral nerve care.
By Epineuron Technologies Inc. · Via Business Wire · May 13, 2026